ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases-Reference-Cited by-同舟云学术

ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases

Published:2023-04-21 Issue:9 Volume:30 Page:5386-5387
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Bond Marinde J. G.,Punt Cornelis J. A.,Swijnenburg Rutger-Jan

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-13513-4.pdf

Reference8 articles.

1. Jones RP, Vauthey JN, Adam R, et al. Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg. 2012;99(9):1263–9. https://doi.org/10.1002/bjs.8835.

2. Hellingman T, de Swart ME, Joosten JJA, et al. The value of a dedicated multidisciplinary expert panel to assess treatment strategy in patients suffering from colorectal cancer liver metastases. Surg Oncol. 2020;35:412–7. https://doi.org/10.1016/j.suronc.2020.09.024.

3. Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11(1):38–47. https://doi.org/10.1016/S1470-2045(09)70330-4.

4. Huiskens J, Bolhuis K, Engelbrecht MR, et al. Outcomes of resectability assessment of the Dutch Colorectal Cancer Group liver metastases expert panel. J Am Coll Surg. 2019;229(6):523–32. https://doi.org/10.1016/j.jamcollsurg.2019.08.1445.

5. Ignatavicius P, Oberkofler CE, Chapman WC, et al. Choices of therapeutic strategies for colorectal liver metastases among expert liver surgeons: a throw of the dice? Ann Surg. 2020;272(5):715–22. https://doi.org/10.1097/SLA.0000000000004331.